Level/ Typ |
Kode |
Anzeigename |
Kodesystem |
Beschreibung |
0-S |
1 |
Allgemeiner Laborbefund |
1.2.40.0.34.5.11 |
|
1-L |
10 |
Probeninformation |
1.2.40.0.34.5.11 |
|
1-L |
20 |
Befundbewertung |
1.2.40.0.34.5.11 |
|
1-S |
100 |
Blutgruppenserologie/Immungenetik |
1.2.40.0.34.5.11 |
|
2-L |
101 |
Blutgruppenserologie |
1.2.40.0.34.5.11 |
|
2-L |
102 |
HLA-Diagnostik |
1.2.40.0.34.5.11 |
|
2-L |
103 |
HPA-Diagnostik |
1.2.40.0.34.5.11 |
|
1-S |
200 |
Blutgasanalyse |
1.2.40.0.34.5.11 |
|
2-S |
201 |
Blutgasanalyse Arteriell |
1.2.40.0.34.5.11 |
|
2-S |
202 |
Blutgasanalyse Venös |
1.2.40.0.34.5.11 |
|
2-L |
203 |
Blutgasanalyse Nabelschnurblut |
1.2.40.0.34.5.11 |
|
1-S |
300 |
Hämatologie |
1.2.40.0.34.5.11 |
|
2-S |
301 |
Blutbild |
1.2.40.0.34.5.11 |
|
3-L |
AKLAM |
Akt.Lymphoz.abs.mi. |
1.2.40.0.34.5.11 |
|
3-L |
AKLRM |
Akt.Lymphoz.rel.mi. |
1.2.40.0.34.5.11 |
|
2-S |
302 |
Knochenmark Morphologie |
1.2.40.0.34.5.11 |
|
2-S |
303 |
Immunphänotypisierung |
1.2.40.0.34.5.11 |
|
3-L |
FZA10AK |
FZA10AK |
1.2.40.0.34.5.11 |
|
3-L |
FZA4R |
FZA4R |
1.2.40.0.34.5.11 |
|
3-L |
FZA510AK |
FZA510AK |
1.2.40.0.34.5.11 |
|
3-L |
FZA5AK |
FZA5AK |
1.2.40.0.34.5.11 |
|
3-L |
FZAKLEU |
FZAKLEU |
1.2.40.0.34.5.11 |
|
3-L |
FZALZP |
FZALZP |
1.2.40.0.34.5.11 |
|
3-L |
FZBAL |
FZBAL |
1.2.40.0.34.5.11 |
|
3-L |
FZDNA |
FZDNA |
1.2.40.0.34.5.11 |
|
3-L |
FZIMSTA |
FZIMSTA |
1.2.40.0.34.5.11 |
|
3-L |
FZLK |
FZLK |
1.2.40.0.34.5.11 |
|
3-L |
FZLYPA |
FZLYPA |
1.2.40.0.34.5.11 |
|
3-L |
FZMYVD |
FZMYVD |
1.2.40.0.34.5.11 |
|
3-L |
FZMYVL |
FZMYVL |
1.2.40.0.34.5.11 |
|
3-L |
FZZAP70 |
FZZAP70 |
1.2.40.0.34.5.11 |
|
2-S |
304 |
Molekulare Diagnostik |
1.2.40.0.34.5.11 |
|
1-S |
400 |
Hämostaseologie |
1.2.40.0.34.5.11 |
|
2-S |
401 |
Hämostaseologie Globaltests |
1.2.40.0.34.5.11 |
|
3-L |
CFTIN |
Clot Form.Time INTEM |
1.2.40.0.34.5.11 |
|
3-L |
CFTEX |
Clot Form.Time EXTEM |
1.2.40.0.34.5.11 |
|
3-L |
CFTNA |
Clot Form.Time NATEM |
1.2.40.0.34.5.11 |
|
3-L |
CTAPT |
Clotting Time APTEM |
1.2.40.0.34.5.11 |
|
3-L |
CTEXT |
Clotting Time EXTEM |
1.2.40.0.34.5.11 |
|
3-L |
CTHEP |
Clotting Time HEPTEM |
1.2.40.0.34.5.11 |
|
3-L |
CTINT |
Clotting Time INTEM |
1.2.40.0.34.5.11 |
|
3-L |
CTNAT |
Clotting Time NATEM |
1.2.40.0.34.5.11 |
|
3-L |
MCFEX |
Max.Clot Firmn.EXTEM |
1.2.40.0.34.5.11 |
|
3-L |
MCFFI |
Max.Clot Firmn.FIBT. |
1.2.40.0.34.5.11 |
|
3-L |
MCFIN |
Max.Clot Firmn.INTEM |
1.2.40.0.34.5.11 |
|
3-L |
MCFNA |
Max.Clot Firmn.NATEM |
1.2.40.0.34.5.11 |
|
3-L |
MLEXT |
Maximal Lyse EXTEM |
1.2.40.0.34.5.11 |
|
3-L |
MLINT |
Maximal Lyse INTEM |
1.2.40.0.34.5.11 |
|
3-L |
MLNAT |
Maximal Lyse NATEM |
1.2.40.0.34.5.11 |
|
3-L |
NRMTC |
Normotest /KB |
1.2.40.0.34.5.11 |
|
3-L |
THRTC |
Thrombotest /KB |
1.2.40.0.34.5.11 |
|
3-L |
NORMT |
Normotest |
1.2.40.0.34.5.11 |
|
3-L |
THROT |
Thrombotest |
1.2.40.0.34.5.11 |
|
3-L |
INRTT |
INRTT |
1.2.40.0.34.5.11 |
|
3-L |
INRST |
INRST |
1.2.40.0.34.5.11 |
|
3-L |
APTTF |
aPTT Fakt.-sens. |
1.2.40.0.34.5.11 |
|
3-L |
PFAINT |
PFAINT |
1.2.40.0.34.5.11 |
|
2-S |
402 |
Einzelfaktoranalysen |
1.2.40.0.34.5.11 |
|
3-L |
HMWKA |
HMWK Aktivität |
1.2.40.0.34.5.11 |
|
3-L |
PKA |
Präkallikrein Akt. |
1.2.40.0.34.5.11 |
|
3-L |
VWGPI |
vWF Aktiv. (GPIb-R) |
1.2.40.0.34.5.11 |
|
3-L |
ADAA |
ADAMTS 13 Aktivität |
1.2.40.0.34.5.11 |
|
2-S |
403 |
Thrombophilie Tests |
1.2.40.0.34.5.11 |
|
3-L |
PTTL2 |
aPTT Lupus-s. 1+2 NP |
1.2.40.0.34.5.11 |
|
3-L |
LABPQ |
LA-Bestät. aPTT ql. |
1.2.40.0.34.5.11 |
|
3-L |
dRVV2 |
dRVVT 1+2 NP |
1.2.40.0.34.5.11 |
|
3-L |
LBDR1 |
LA Bst.dRVVT-R.1+1NP |
1.2.40.0.34.5.11 |
|
3-L |
LBDR2 |
LA Bst.dRVVT-R.1+2NP |
1.2.40.0.34.5.11 |
|
3-L |
LABD2 |
LA Best.dRVVT 1+2 NP |
1.2.40.0.34.5.11 |
|
3-L |
LABDQ |
LA-Bestät. dRVVT ql. |
1.2.40.0.34.5.11 |
|
3-L |
LABDR |
LA-Bestät. dRVVT-Rto |
1.2.40.0.34.5.11 |
|
3-L |
PSREG |
Phosphatids.-AK IgG |
1.2.40.0.34.5.11 |
|
3-L |
PSREM |
Phosphatids.-AK IgM |
1.2.40.0.34.5.11 |
|
3-L |
PCPWY |
Protein C Pathw. |
1.2.40.0.34.5.11 |
|
3-L |
PCP5D |
Prot.C Pwy(V-d.Pl.) |
1.2.40.0.34.5.11 |
|
3-L |
APCRZ |
APC-Res. (Ger.Z.) |
1.2.40.0.34.5.11 |
|
3-L |
APCRQ |
APC-Resistenz(qual.) |
1.2.40.0.34.5.11 |
|
3-L |
PA675 |
PAI-1 Mut. 675 4G/5G |
1.2.40.0.34.5.11 |
|
3-L |
PA844 |
PAI-1 Mut. 844A>G |
1.2.40.0.34.5.11 |
|
1-S |
500 |
Klinische Chemie |
1.2.40.0.34.5.11 |
|
2-S |
501 |
Entzündungsmarker |
1.2.40.0.34.5.11 |
|
2-S |
502 |
Niere/Elektrolyte |
1.2.40.0.34.5.11 |
|
3-L |
SAMP |
SAMP |
1.2.40.0.34.5.11 |
|
3-L |
VL24U |
VL24U |
1.2.40.0.34.5.11 |
|
3-L |
GFRCG |
GFRCG |
1.2.40.0.34.5.11 |
|
3-L |
BUNVO |
BUNVO |
1.2.40.0.34.5.11 |
|
3-L |
BUNNA |
BUNNA |
1.2.40.0.34.5.11 |
|
3-L |
BUNRR |
BUNRR |
1.2.40.0.34.5.11 |
|
2-S |
503 |
Kardiale Marker |
1.2.40.0.34.5.11 |
|
2-S |
504 |
Leber/Pankreas |
1.2.40.0.34.5.11 |
|
2-S |
505 |
Hämolysemarker |
1.2.40.0.34.5.11 |
|
2-S |
506 |
Eisenstoffwechsel |
1.2.40.0.34.5.11 |
|
2-S |
507 |
Glukosestoffwechsel |
1.2.40.0.34.5.11 |
|
2-S |
508 |
Fettstoffwechsel |
1.2.40.0.34.5.11 |
|
2-S |
509 |
Proteindiagnostik |
1.2.40.0.34.5.11 |
|
3-L |
MGRAR |
MGRAR |
1.2.40.0.34.5.11 |
|
3-L |
LDLO |
Oxidiertes LDL |
1.2.40.0.34.5.11 |
|
1-S |
600 |
Endokrinologie |
1.2.40.0.34.5.11 |
|
2-S |
601 |
Adrenocortikales System |
1.2.40.0.34.5.11 |
|
2-S |
602 |
Katecholamine |
1.2.40.0.34.5.11 |
|
2-S |
603 |
Schilddrüsendiagnostik |
1.2.40.0.34.5.11 |
|
2-S |
604 |
Geschlechtshormone |
1.2.40.0.34.5.11 |
|
2-S |
605 |
Glukosestoffwechsel |
1.2.40.0.34.5.11 |
|
2-S |
606 |
Endokrinologie |
1.2.40.0.34.5.11 |
|
1-S |
700 |
Vitamine |
1.2.40.0.34.5.11 |
|
2-S |
701 |
Vitamine |
1.2.40.0.34.5.11 |
|
3-L |
AVB12 |
AVB12 |
1.2.40.0.34.5.11 |
|
1-S |
800 |
Tumormarker |
1.2.40.0.34.5.11 |
|
2-S |
801 |
Tumormarker |
1.2.40.0.34.5.11 |
|
1-S |
900 |
Toxikologie |
1.2.40.0.34.5.11 |
|
2-S |
901 |
HarnScreening |
1.2.40.0.34.5.11 |
|
2-S |
902 |
Blut |
1.2.40.0.34.5.11 |
|
1-S |
1000 |
TDM |
1.2.40.0.34.5.11 |
|
2-S |
1001 |
Antibiotika |
1.2.40.0.34.5.11 |
|
2-S |
1002 |
Virostatika |
1.2.40.0.34.5.11 |
|
2-S |
1003 |
Antiepileptika |
1.2.40.0.34.5.11 |
|
2-S |
1004 |
Kardiaka |
1.2.40.0.34.5.11 |
|
2-S |
1005 |
Immunsuppressiva |
1.2.40.0.34.5.11 |
|
2-S |
1006 |
Sonstige |
1.2.40.0.34.5.11 |
|
1-S |
1100 |
Virologie |
1.2.40.0.34.5.11 |
|
2-S |
1101 |
HIV |
1.2.40.0.34.5.11 |
|
2-S |
1102 |
Hepatitis A |
1.2.40.0.34.5.11 |
|
2-S |
1103 |
Hepatitis B |
1.2.40.0.34.5.11 |
|
2-S |
1104 |
Hepatitis C |
1.2.40.0.34.5.11 |
|
2-S |
1105 |
Komplementbindungsreaktion |
1.2.40.0.34.5.11 |
|
2-S |
1106 |
Immunoassays |
1.2.40.0.34.5.11 |
|
2-S |
1107 |
PCR-Diagnostik |
1.2.40.0.34.5.11 |
|
3-L |
EVPQX |
Ent.v.-RNA qn/SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
IAPQX |
Inf.A-V-RNAqn/SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
IBPQX |
Inf.B-V-RNAqn/SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
MPPQX |
MPV-RNA qn. /SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
P1PQX |
PIV-1-RNA qn/SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
P2PQX |
PIV-2-RNA qn/SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
P3PQX |
PIV-3-RNA qn./SM PCR |
1.2.40.0.34.5.11 |
|
2-S |
1108 |
Schnelltests |
1.2.40.0.34.5.11 |
|
1-S |
1200 |
Bakteriologie |
1.2.40.0.34.5.11 |
|
2-S |
1201 |
Syphilis-Diagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1202 |
STD |
1.2.40.0.34.5.11 |
|
2-S |
1203 |
Borrelienserologie |
1.2.40.0.34.5.11 |
|
2-S |
1204 |
Chl. Psitakii Diagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1205 |
Schnelltests |
1.2.40.0.34.5.11 |
|
2-S |
1206 |
Tuberkulose Diagnostik |
1.2.40.0.34.5.11 |
|
3-L |
MTQPX |
MTB-DNA qn. /SM PCR |
1.2.40.0.34.5.11 |
|
3-L |
MTBP$ |
MTBP$ |
1.2.40.0.34.5.11 |
|
3-L |
MTBP+ |
MTBP+ |
1.2.40.0.34.5.11 |
|
3-L |
MTBPM |
MTBPM |
1.2.40.0.34.5.11 |
|
3-L |
MTBPR |
MTBPR |
1.2.40.0.34.5.11 |
|
3-L |
MTBPU |
MTBPU |
1.2.40.0.34.5.11 |
|
2-S |
1207 |
Mykoplasmen Diagnostik |
1.2.40.0.34.5.11 |
|
3-L |
MYPQX |
Myc.pn.DNA qn/SM PCR |
1.2.40.0.34.5.11 |
|
2-S |
1208 |
Malariasuche |
1.2.40.0.34.5.11 |
|
3-L |
PLLDH |
Plasmodien-LDH /B |
1.2.40.0.34.5.11 |
|
1-S |
1300 |
Autoantikörperdiagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1301 |
Rheumatoide Arthritis-assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
CCPAK |
CCP-AK |
1.2.40.0.34.5.11 |
|
3-L |
MCVAK |
MCV-AK |
1.2.40.0.34.5.11 |
|
2-S |
1302 |
Kollagenose-assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
CHRTF |
ANA chromosom. Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
NUKTF |
ANA nukleolär Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
HOMTF |
ANA homogen Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
HOMTF |
ANA homogen Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
SPFTF |
ANA speck.fein Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
SPATF |
ANA speck.atyp.Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
NUKTF |
ANA nukleolär Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
NDQF |
ANA nucl. dot ql. IF |
1.2.40.0.34.5.11 |
|
3-L |
NDTF |
ANA nucl. dot Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
MNDQF |
ANA m.nucl.dot ql.IF |
1.2.40.0.34.5.11 |
|
3-L |
MNDTF |
ANA m.nucl.dot Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
KMTTF |
ANA Kernmatrix Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
SPIQF |
ANA Spindel qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
SPITF |
ANA Spindel Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
CSMTF |
ANA centrosom. Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
PCAQF |
PCNA-AK qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
PCATF |
PCNA-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
PRAQF |
Kernporen-AK ql. IF |
1.2.40.0.34.5.11 |
|
3-L |
PRATF |
Kernporen-AK T. IF |
1.2.40.0.34.5.11 |
|
3-L |
HP2FI |
HEP2-Ze. IF Interpr. |
1.2.40.0.34.5.11 |
|
3-L |
NSMAK |
Nukleosomen-AK |
1.2.40.0.34.5.11 |
|
3-L |
S52AK |
SS-A/Ro-52-AK |
1.2.40.0.34.5.11 |
|
3-L |
S60AK |
SS-A/Ro-60-AK |
1.2.40.0.34.5.11 |
|
3-L |
CNBAK |
CENP-B-AK |
1.2.40.0.34.5.11 |
|
3-L |
S52AQ |
SS-A/Ro-52-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
S60AQ |
SS-A/Ro-60-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
RNPSQ |
RNPSQ |
1.2.40.0.34.5.11 |
|
3-L |
U170Q |
U1-snRNP-70-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
U170Q |
U1-snRNP-70-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
U1RAQ |
U1-snRNP-A-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
U1RGQ |
U1-snRNP-AK ql. |
1.2.40.0.34.5.11 |
|
3-L |
U1RGQ |
U1-snRNP-AK ql. |
1.2.40.0.34.5.11 |
|
3-L |
U1RCQ |
U1-snRNP-C-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
SMBAQ |
SmB-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
SMDAQ |
SmD-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
CNBAQ |
CENP-B-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
GOAQF |
Golgi-AK qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
GOATF |
Golgi-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
LYATF |
Lysosomen-AK Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
RIBQF |
Ribosomale-AK ql. IF |
1.2.40.0.34.5.11 |
|
3-L |
RPAQF |
RNA-Polym.-AK ql. IF |
1.2.40.0.34.5.11 |
|
3-L |
RPATF |
RNA-Polym.-AK Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
PMSQF |
PM-Scl-AK qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
PMSTF |
PM-Scl-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
VMATF |
Vimentin-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
VNATF |
Vinkulin-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
P7AQF |
PL-7/PL-12-AK ql. IF |
1.2.40.0.34.5.11 |
|
3-L |
P7ATF |
PL-7/PL-12-AK Ti. IF |
1.2.40.0.34.5.11 |
|
3-L |
SRATF |
SRP-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
SRPAK |
SRP-AK |
1.2.40.0.34.5.11 |
|
2-S |
1303 |
Lebererkrankungen-assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
LKAQF |
LKM-AK qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
SMAFI |
SMA(ASMA)IF Interpr. |
1.2.40.0.34.5.11 |
|
3-L |
SMAI |
SMA(ASMA) Interpret. |
1.2.40.0.34.5.11 |
|
3-L |
AKAQF |
Aktin-AK qual. IF |
1.2.40.0.34.5.11 |
|
3-L |
AKATF |
Aktin-AK Titer IF |
1.2.40.0.34.5.11 |
|
3-L |
AMM4 |
AMA-M4 |
1.2.40.0.34.5.11 |
|
3-L |
AMM9 |
AMA-M9 |
1.2.40.0.34.5.11 |
|
3-L |
SLAAQ |
SLA/LP-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
FAKTA |
F-Aktin-AK |
1.2.40.0.34.5.11 |
|
3-L |
FAKAQ |
F-Aktin-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
GP2AQ |
GP210-AK qual. |
1.2.40.0.34.5.11 |
|
2-S |
1304 |
Perniziöse Anämie assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
2-S |
1305 |
Vasculitis-assoziierte Antikörper |
1.2.40.0.34.5.11 |
|
3-L |
XANQF |
x-ANCA(atyp.p) ql.IF |
1.2.40.0.34.5.11 |
|
3-L |
AANTF |
Atyp. ANCA Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
PR3AC |
PR3-AK cELISA |
1.2.40.0.34.5.11 |
|
3-L |
MPOC |
MPO-AK cELISA |
1.2.40.0.34.5.11 |
|
3-L |
ELAAQ |
Elastase-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
CATAQ |
Cathepsin-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
LYSAQ |
Lysozym-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
LACAQ |
Lactoferrin-AK qual. |
1.2.40.0.34.5.11 |
|
3-L |
BPIAQ |
BPI-AK qual. |
1.2.40.0.34.5.11 |
|
2-S |
1306 |
Goodpasture Syndrom assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
2-S |
1307 |
IBD assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
ASCAQ |
ASCA qual. |
1.2.40.0.34.5.11 |
|
3-L |
TTAGQ |
tTGA IgG qual. |
1.2.40.0.34.5.11 |
|
3-L |
TTGAQ |
tTGA qual. |
1.2.40.0.34.5.11 |
|
2-S |
1308 |
Diabetes Mellitus assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
2-S |
1309 |
Paraneoplasie assoziierte Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
KIAQ |
Ki-AK qual. |
1.2.40.0.34.5.11 |
|
2-S |
1310 |
Sonstige Autoantikörper |
1.2.40.0.34.5.11 |
|
3-L |
SPDTF |
Speicheldr.-AK Ti.IF |
1.2.40.0.34.5.11 |
|
3-L |
SRAQF |
SRP-AK qual. IF |
1.2.40.0.34.5.11 |
|
1-S |
1400 |
Harndiagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1401 |
Harnstreifen |
1.2.40.0.34.5.11 |
|
3-L |
ERYSU |
ERYSU |
1.2.40.0.34.5.11 |
|
2-S |
1402 |
Harnsediment |
1.2.40.0.34.5.11 |
|
3-L |
G1ERV |
G1-Erythrozyt.rl./US |
1.2.40.0.34.5.11 |
|
3-L |
GLERV |
Glomerul.Ery.rel./US |
1.2.40.0.34.5.11 |
|
3-L |
PILZV |
Pilze /US |
1.2.40.0.34.5.11 |
|
3-L |
RUEPV |
Rundepithelien /US |
1.2.40.0.34.5.11 |
|
3-L |
PSZLV |
Pseudozylinder /US |
1.2.40.0.34.5.11 |
|
3-L |
ZGLMU |
Ziegelmehlsedim. /U |
1.2.40.0.34.5.11 |
|
2-S |
1403 |
Harnchemie |
1.2.40.0.34.5.11 |
|
3-L |
MGU |
MGU |
1.2.40.0.34.5.11 |
|
3-L |
B1GRU |
B1GRU |
1.2.40.0.34.5.11 |
|
3-L |
B2GRU |
B2GRU |
1.2.40.0.34.5.11 |
|
3-L |
B1GLU |
B1GLU |
1.2.40.0.34.5.11 |
|
3-L |
B2GLU |
B2GLU |
1.2.40.0.34.5.11 |
|
3-L |
FLAMU |
FLAMU |
1.2.40.0.34.5.11 |
|
2-S |
1404 |
Katecholamine |
1.2.40.0.34.5.11 |
|
2-S |
1405 |
Kortikoide |
1.2.40.0.34.5.11 |
|
1-S |
1500 |
Stuhldiagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1501 |
Stuhldiagnostik |
1.2.40.0.34.5.11 |
|
1-S |
1600 |
Liquordiagnostik |
1.2.40.0.34.5.11 |
|
2-S |
1601 |
Liquordiagnostik |
1.2.40.0.34.5.11 |
|
3-L |
MNZRL |
MNZRL |
1.2.40.0.34.5.11 |
|
3-L |
NEURL |
NEURL |
1.2.40.0.34.5.11 |
|
3-L |
FKAPL |
FKAPL |
1.2.40.0.34.5.11 |
|
3-L |
FLAML |
FLAML |
1.2.40.0.34.5.11 |
|
3-L |
FKAPI |
FKAPI |
1.2.40.0.34.5.11 |
|
1-S |
1700 |
Sondermaterialien |
1.2.40.0.34.5.11 |
|
2-S |
1701 |
Sondermaterialien |
1.2.40.0.34.5.11 |
|
3-L |
THRX |
THRX |
1.2.40.0.34.5.11 |
|
3-L |
ERYX |
ERYX |
1.2.40.0.34.5.11 |
|
3-L |
HBX |
HBX |
1.2.40.0.34.5.11 |
|
3-L |
HKTX |
HKTX |
1.2.40.0.34.5.11 |
|
3-L |
NEUAX |
NEUAX |
1.2.40.0.34.5.11 |
|
3-L |
EOSAX |
EOSAX |
1.2.40.0.34.5.11 |
|
3-L |
BASAX |
BASAX |
1.2.40.0.34.5.11 |
|
3-L |
LYMAX |
LYMAX |
1.2.40.0.34.5.11 |
|
3-L |
MONAX |
MONAX |
1.2.40.0.34.5.11 |
|
3-L |
IMGAX |
IMGAX |
1.2.40.0.34.5.11 |
|
3-L |
EOSRX |
EOSRX |
1.2.40.0.34.5.11 |
|
3-L |
BASRX |
BASRX |
1.2.40.0.34.5.11 |
|
3-L |
IMGRX |
IMGRX |
1.2.40.0.34.5.11 |
|
3-L |
B1GRX |
B1GRX |
1.2.40.0.34.5.11 |
|
3-L |
B2GRX |
B2GRX |
1.2.40.0.34.5.11 |
|
3-L |
B1GX |
B1GX |
1.2.40.0.34.5.11 |
|
3-L |
B2GX |
B2GX |
1.2.40.0.34.5.11 |
|
3-L |
FERRX |
FERRX |
1.2.40.0.34.5.11 |
|
2-S |
1702 |
Peritonealdialysat |
1.2.40.0.34.5.11 |
|
3-L |
THRY |
THRY |
1.2.40.0.34.5.11 |
|
3-L |
ERYY |
ERYY |
1.2.40.0.34.5.11 |
|
3-L |
HBY |
HBY |
1.2.40.0.34.5.11 |
|
3-L |
HKTY |
HKTY |
1.2.40.0.34.5.11 |
|
3-L |
NEURY |
NEURY |
1.2.40.0.34.5.11 |
|
3-L |
EOSRY |
EOSRY |
1.2.40.0.34.5.11 |
|
3-L |
BASRY |
BASRY |
1.2.40.0.34.5.11 |
|
3-L |
LYMRY |
LYMRY |
1.2.40.0.34.5.11 |
|
3-L |
MONRY |
MONRY |
1.2.40.0.34.5.11 |
|
3-L |
TPY |
TPY |
1.2.40.0.34.5.11 |
|
3-L |
ALBY |
ALBY |
1.2.40.0.34.5.11 |
|
3-L |
CHOLY |
CHOLY |
1.2.40.0.34.5.11 |
|
3-L |
TRIGY |
TRIGY |
1.2.40.0.34.5.11 |
|
1-S |
1800 |
Allergiediagnostik/Globalmarker |
1.2.40.0.34.5.11 |
|
2-S |
1801 |
Allergiediagnostik/Globalmarker |
1.2.40.0.34.5.11 |
|
3-L |
DAO |
DAO |
1.2.40.0.34.5.11 |
|
1-S |
1900 |
Allergiediagnostik Spez. IGE |
1.2.40.0.34.5.11 |
|
2-S |
1901 |
Gräserpollen RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1902 |
Baumpollen RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1903 |
Kräuterpollen RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1904 |
Milben RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1905 |
Epidermale Tierallergene RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1906 |
Mikroorganismen RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1907 |
Nahrungsmittel RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1908 |
Insektengifte RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1909 |
Berufliche Allergene RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1910 |
Diverse Allergene RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1911 |
Medikamente RAST Klassen |
1.2.40.0.34.5.11 |
|
2-S |
1912 |
Gräserpollen IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1913 |
Baumpollen IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1914 |
Kräuterpollen IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1915 |
Milben IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1916 |
Epidermale Tierallergene IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1917 |
Mikroorganismen IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1918 |
Nahrungsmittel IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1919 |
Insektengifte IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1920 |
Berufliche Allergene IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1921 |
Diverse Allergene IGE quant. |
1.2.40.0.34.5.11 |
|
2-S |
1922 |
Medikamente IGE quant. |
1.2.40.0.34.5.11 |
|